Low Performance of Sinovac Vaccine Particularly With Belatacept Therapy in a Study With Different Types of COVID-19 Vaccines in Transplanted Patients
- 1 March 2023
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 55 (3) , 500-507
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort studyClinical Microbiology and Infection, 2021
- Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccineKidney International, 2021
- Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipientsKidney International, 2021
- SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in ColombiaTransplantation Proceedings, 2021
- Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusAmerican Journal of Transplantation, 2021
- Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipientsAmerican Journal of Transplantation, 2021
- Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With BelataceptTransplantation, 2021
- Covid-19 and Kidney TransplantationNew England Journal of Medicine, 2020
- COVID-19 in solid organ transplant recipients: Initial report from the US epicenterAmerican Journal of Transplantation, 2020
- Kinetics of antibody response to influenza vaccination in renal transplant recipientsTransplant Immunology, 2019